Default Theme
अखिल भारतीय आयुर्विज्ञान संस्थान, नई दिल्ली
All India Institute Of Medical Sciences, New Delhi
कॉल सेंटर:  011-26589142

Teaching Schedule

Dr. Sudhir Chandra Sarangi



Name: Dr. Sudhir Chandra Sarangi, MBBS, MD, DM (Clinical Pharmacology), MAMS

डॉसुधीर चन्द्र सरंगी,

Designation: Additional Professor

अपर प्रोफेसर

Affiliation: Department of Pharmacology, All India Institute of Medical Sciences, New Delhi

भेषजगुणविज्ञानविभाग, अखिलभारतीय आयुर्विज्ञानसंस्थान, नईदिल्ली

Address: Room No-5009, 5th Floor,

                 Department of Pharmacology,

                 Convergence Block,

                 All India Institute of Medical Sciences,

                 New Delhi-110029

Phone: +91 8518881757, 011-26549259

Email Idयह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए.

Academic Details:

  • D.M. (Clinical Pharmacology) in the year 2013, All India Institute of Medical Sciences, New Delhi.

  • M.D. (Pharmacology) in the year 2009, All India Institute of Medical Sciences, New Delhi

  • M.B.B.S (Hons) in the year 2005, MKCG Medical College, Berhampur

Research Interest/Areas: Clinical Pharmacology, Neuropharmacology, Pharmacovigilance, Drug Safety, Pharmacoeconomics, Computational Pharmacology

Fellowships/ Memberships/ Awards:

  • Awarded membership by National Academy of Medical Sciences

  • Awarded ‘Bursary’ to attend the 34th International Epilepsy Congress by International League Against Epilepsy (2021)

  • Obtained Certificate of Achievement for poster presentation at 34th, 33rd and 32nd International Epilepsy Congress, 2021, 2019 & 2017.

  • Best Paper Award (2nd prize) in 20th Joint Annual Conference of Indian Epilepsy Society and Indian Epilepsy Association (ECON 2019)

  • Obtained ICMR International Travel support for Non-ICMR scientists for attending 33rd International Epilepsy Congress held at Bangkok, Thailand 22-26 June 2019.

Life Membership of societies:

  • National Academy of Medical Sciences (India)

  • Indian Pharmacology society

  • Indian Society of Rational Pharmacotherapeutics

  • The Association of Physiologists & Pharmacologist of India

  • Society of Toxicology, India

  • Indian Epilepsy Society

  • Indian Society of Nanomedicine

  • Delhi Pharmacological Society

Academic/Teaching/ Administrative activities

  • Opportunity to guide thesis works of 27 students including currently pursuing and completed (chief guide of 10 students and co-guide of 17 students).

  • Part of the team for UG curriculum preparation in AIIMS, New Delhi.

  • Nodal faculty from Pharmacology Department to coordinate with SET Facility

  • Part of the team for preparation of UG (MBBS) Practical manual for Pharmacology in AIIMS, New Delhi

  • Deputy coordinator of Adverse Drug Reaction Monitoring Center at AIIMS under Pharmacovigilance Programme of India

Publications (10 recent)

  1. Sarangi SC, Medhi B, Prakash A, Prakash J, Gupta YK. Questionnaire-based Pan-India survey for impact assessment of National Formulary of India. Indian J Pharmacol. 2021 Mar-Apr;53(2):115-124.

  2. Sarangi SC, Sopory P, Reeta KH. Chronic Neurological Disorders: Genetic and Epigenetic Markers for Monitoring of Pharmacotherapy. Neurol India. 2021 Mar-Apr;69(2):252-259.

  3. Kumar R, Arora R, Sarangi SC, Ganeshan N S, Agarwal A, Kaleekal T, Gupta YK. Pharmacodynamic and pharmacokinetic interactions of hydroalcoholic leaf extractof Centellaasiatica with valproate and phenytoin in experimental models ofepilepsy in rats. J Ethnopharmacol. 2021 Apr 24;270:113784.

  4. Sarangi SC, Sopory P, Pattnaik SS, Reeta KH. Antibody-drug conjugates, cancer immunotherapy, and metronomic chemotherapy as novel approaches in cancermanagement. Indian J Pharmacol. 2020 Sep-Oct;52(5):402-413.

  5. Sarangi SC, Kaur N, Tripathi M. Need for pharmacoeconomic consideration of antiepileptic drugs monotherapy treatment in persons with epilepsy. Saudi Pharm J. 2020;28(10):1228-1237. (IF-2.879)

  6. Sarangi SC, Pattnaik SS, Joshi D, Chandra PP, Kaleekal T. Adjuvant role of Ocimum sanctum hydroalcoholic extract with carbamazepine and phenytoin in experimental model of acute seizures. Saudi Pharm J. 2020 In press. (IF-2.879)

  7. Kumar S, Sarangi SC, Tripathi M, Ramanujam B, Gupta YK. Seizure recurrence risk in persons with epilepsy undergoing antiepileptic drug tapering. Acta Neurol Scand. 2020 Jan;141(1):65-76. (IF- 2.852)

  8. Sarangi SC, Pattnaik SS, Katyal J, Kaleekal T, Dinda AK. An interaction study of Ocimum sanctum L. and levetiracetam in pentylenetetrazole kindling model of epilepsy. J Ethnopharmacol. 2020 Mar 1;249:112389. (IF- 3.414)

  9. Kumar S, Sarangi SC, Tripathi M, Gupta YK.Evaluation of adverse drug reaction profile of antiepileptic drugs in persons with epilepsy: A cross-sectional study. Epilepsy Behav. 2020 Apr;105:106947.(IF- 2.378)

  10. Mishra A, Sarangi SC, Reeta K. First-in-human dose: current status review for better future perspectives. Eur J ClinPharmacol. 2020 Jun 3. doi: 10.1007/s00228-020-02924-x. (IF- 2.774)


Author of books/book chapters: Eight chapters

  1. Author of one chapter in ‘IAN Textbook of Neurology’ by Dr A. A. Mukherjee and Dr G. Singh. Edition 2018.

  2. Author of one chapter in ‘Nanogels in Biomedical Applications’ by A Vasisth, AK Kaushik, S Ahmad, M Nair, Royal Society of Chemistry, UK, Edition 2018.

  3. Author of six chapters in the book 'Advanced Pharmacology' by B. Medhi& A. Prakash, Edition 2014.



Dr Jagriti Bhatia


Designation:                           Professor

Office Address:                     Department of Pharmacology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi  110 029 

Office Tel:                              011-2654 6476;  26593282

E-mail:                                    यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए.

Education:                             MBBS (Lady Hardinge Medical College, New Delhi, 1995) 

                                                MD Pharmacology (UCMS-GTB Hospital, Delhi, 1999)

Departmental duties:            Engaged in teaching of  MBBS (3rd, 4th and 5th Semester), BSc Nursing (Hons), MSc, MD and PhD students

Field of Research:                 Herbal (Indigenous) Pharmacology

                                                Cardiovascular Pharmacology


                                                Pulmonary fibrosis




  1. AIIMS Excellence Research Award 2015 Commendation Certificate for the year 2014-2015.
  2. ISH 2014 International Forum Poster Prize for the Asia and Australasia Region at Athens, Greece, 2014.

Research Publications

  1. Gamad N,  Malik S, Suchal K, Vasisht S, Tomar A, Arava S, Arya DS, Bhatia J. Metformin alleviates bleomycin-induced pulmonary fibrosis in rats: Pharmacological effects and molecular mechanisms. Biomed Pharmacother  2018; 97: 1544–1553.
  2. Khan SI, Malhotra RK, Rani N, Sahu AK, Tomar A, Garg S, Nag TC, Ray R, Ojha S, Arya DS, Bhatia J. Febuxostat Modulates MAPK/NF-κBp65/TNF-α Signaling in Cardiac Ischemia-Reperfusion Injury.Oxid Med Cell Longev. 2017;2017:8095825. 
  3. Tomar A, Vasisth S, Khan SI, Malik S, Nag TC, Arya DS, Bhatia J. Galangin ameliorates cisplatin induced nephrotoxicity in vivo by modulation of oxidative stress, apoptosis and inflammation through interplay of MAPK signaling cascade. Phytomedicine.2017;34:154-161.
  4. Malik S, Suchal K, Khan SI, Bhatia J, Kishore K, Dinda AK, Arya DS. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK/NF-κB/TNFα and TGF-β1/MAPK/Fibronectin pathways.Am J Physiol Renal Physiol.2017;313(2):F414-F422.
  5. Suchal K, Malik S, Gamad N, Malhotra RK, Goyal SN, Bhatia J, Arya DS. Kampeferol protects against oxidative stress and apoptotic damage in experimental model of isoproterenol-induced cardiac toxicity in rats.Phytomedicine. 2016;23(12):1401-1408.
  6. Malik S, Suchal K, Bhatia J, Khan SI, Vasisth S, Tomar A, Goyal S, Kumar R, Arya DS, OjhaSK.Therapeutic Potential and Molecular Mechanisms of Emblica officinalisGaertn in Countering Nephrotoxicity in Rats Induced by the Chemotherapeutic Agent Cisplatin. Front Pharmacol 2016;7:350. eCollection 2016.
  7. Rani N, Bharti S, Tomar A, Dinda AK, Arya DS, Bhatia J. Inhibition of PARP activation by enalapril is crucial for its renoprotective effect in cisplatin-induced nephrotoxicity in rats.Free Radic Res 2016;50(11):1226-1236.    
  8. Malik S, Suchal K, Bhatia J, Gamad N, Dinda AK, Gupta YK, Arya DS. Molecular mechanisms underlying attenuation of cisplatin-induced acute kidney injury by epicatechingallate. Lab Invest.2016; 96(8):853-61.
    1. Malik S, Suchal K, Gamad N, Dinda AK, Arya DS, Bhatia J .Telmisartan ameliorates cisplatin-induced nephrotoxicity by inhibiting MAPK mediated inflammation and apoptosis.Eur J Pharmacol. 2015; 748:54-60.  
  1. Malik S, Bhatia J, Suchal K, Gamad N, Dinda AK, Gupta YK, Arya DS. Nobiletin ameliorates cisplatin-induced acute kidney injury due to its anti-oxidant, anti-inflammatory and anti-apoptotic effects.ExpToxicolPathol. 2015;67(7-8):427-33. 


Dr. Harlokesh Narayan Yadav


Curriculum Vitae


Harlokesh Narayan Yadav

Associate Professor

Dept. of Pharmacology, AIIMS New Delhi

Phone Number-         Off- 011-26548565, Lab - 26549272

E-mail Id-                                    यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए.


Research Interests:



Involved in the Undergraduate and Post graduate teaching (MBBS and MD) and mentoring PhD students in All India Institute of Medical Sciences, New Delhi


 Major Area: Molecular Pharmacology/Cardiovascular Pharmacology/Nano-Pharmacology

 Cardiac ischemic-reperfusion injury, cardiac hypertrophy, cardiac failure and Pulmonary artery hypertension and In Vitro Screening

Awards and Professional activities:


  1. Gold medal for Dr. Manjeet Singh Award for best research work in the area of molecular Pharmacology by Indian Pharmacological Society.
  2. Gold medal for N.N. Datta Prize for best published work in Indian Journal of Pharmacology by Indian Pharmacological Society.


  1. Serving as Secretary International of Indian Pharmacological Society, India
  2. National Academy of Medical Sciences, New Delhi
  3. Life Member of Indian Pharmacological Society (IPS)
  4. Life Member of Indian Society of Nanomedicine
  5. Life member of InPharm Association
  6. Life member of Indian Pharmacy Graduates Association (IPGA)

GUIDED: 40 PG Students

Experience: 13 Years of academic and research experience


Selected Research Publications:






DOB: 27th May1963


Department of Pharmacology,

All India Institute of Medical Sciences,

Ansari Nagar New Delhi - 110 029, INDIA

Tel: +91-11-2654-6460,  09810882350

E-mail:  यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए.




1. Published >100 Research Papers (Total Impact Factor 125.02, Citation-3200, h-Index- 29)

2. Authored 06 Books/Scientific Series & chapters in book.

3. Guided 48 Theses (PhD-18, MD/MDS -19, M.Pharm / MSc-08).

4. Completed 20 Research projects funded by ICMR, DBT, AIIMS, AYUSH, Govt. of India.


1.Gold Medal, M.Pharm. (Pharmacology) DIPSAR (University of Delhi), 1989.

2.JSPS-Asia Africa Science Platform Programme, Japan Best Paper Award, 2011.

3. Indian Council of Medical Research (ICMR) Award for Biomedical Research, 2013.

4. All India Institute of Medical Sciences (AIIMS) Excellence Research Award, 2016.

5. Dr. B. Mukherjee Prize for Best paper in Indian Journal of Pharmacology, 2016.

6. Dr. D.N. Prasad Memorial Oration Award, ICMR for Biomedical Research, 2017.


Fellowships/ Honours:

1. Fellow of National Academy of Medical Sciences (FAMS), India.     

2. Fellow of Royal Society of Chemistry (FRSC), United Kingdom.

3. Fellow of International Medical Science Academy (FIMSA), India.

4. Fellow of Institution of Chemists (FIC), India.

5. D.Sc. (Honoris Causa), Colombo, Sri Lanka.

6. Fellow of International Council of Ayurveda (FICA), India.



Inflammation, Rheumatoid Arthritis, Indigenous drugs, Medicinal Plant Research


1.   Surender Singh and DK Majumdar (1999).

      Evaluation of gastric antiulcer activity of fixed oil of Ocimum sanctum (Holy Basil)

      Journal of Ethnopharmacology, 65:13-19. (IF:3.055)             

2.   MA Jafri, M Jalis Subhani, Kalim Javed and Surender Singh (2000)

      Hepatoprotective activity of leaves of Cassia Occidentalis against paracetamol and ethyl alcohol intoxication in rats.

      Journal of Ethnopharmocology - 66:355-361. (IF:3.055)             

3.   MA Jafri, M Aslam, Kalim Javed and Surender Singh (2000)

      Effect of Punica granatum Linn (flowers) on blood glucose levels in normal and alloxan induced diabetic rats.

      Journal of Ethnopharmacology - 70:309-314. (IF:3.055)               

4.   MA jafri, Farah, Kalim Javed K and Surender Singh (2001)

      Evaluation of the gastric antiulcerogenic effect of large cardamom (fruits of Ammomum subulatum Roxb.)

      Journal of Ethnopharmacology 75:89-94. (IF:3.055)  


5.   Surender Singh, HMS Rehan and DK Majumdar (2001)

      Effect of Ocimum sanctum fixed oil on blood pressure, blood clotting time and pentobarbitone - induced sleeping time.

      Journal of Ethnopharmacology ,78:139-143. (IF:3.055)             

6.   PK Mediratta, KK Sharma and Surender Singh (2002)

      Evaluation of Immunomodulatory potential of Ocimum sanctum seed oil and its possible mechanism of action.

      Journal of Ethnopharmacology, 80:15-20. (IF:3.055)             


7. Vinod Nair , Surender Singh and YK Gupta (2011).

Evaluation of the disease modifying activity of Colchicum luteum Baker in. experimental arthritis.

      Journal of Ethnopharmacology, 133: 303-307. (IF:3.055)             


8.Surender  Singh, Vinod Nairand Yogendra K Gupta (2012).

     Evaluation of the aphrodisiac activity of Tribulus terrestris Linn. in sexually sluggish male albino rats.

      Journal of Pharmacology & Phamacotherapeutics , 3(1): 43-47.


9. Ritu Karwasra, Prerna Kalra, YK Gupta, Deepika Saini, Ajay Kumar and Surender        Singh (2016).

Pomegranate antioxidant and anti-inflammatory potential ameliorates renoprotection  in cisplatin-induced acute kidney injury.

Food and Function, 7: 3091-3101 (IF: 2.791).

10. Rohit Kumar, Vinod Nair, YK Gupta, Surender Singh and S.Arunraja (2016).

Berberis aristata ameliorates adjuvant-induced arthritis by inhibition of NF-κB and       activating nuclear factor-E2-related factor 2/hem oxygenase (HO)-1 signaling pathway.

Immunological investigations, 45(6): 473-489. (IF: 1.780).


Zo2 Framework Settings

Select one of sample color schemes

Google Font

Menu Font
Body Font
Heading Font


Background Color
Text Color
Link Color
Background Image

Header Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Menu Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Main Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Inset Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Bottom Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image
Background Color
Modules Title
Text Color
Link Color
Background Image
Top of Page